STTK · Shattuck Labs, Inc.
Market Cap
$603.18M
Shares
100.36M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.01
Open$5.86
Day$5.80–6.22
52W close$1.77–8.06
Avg vol 30d1.1M
Short int5.6M · 5.6% float · 7.6d
Short vol74%
Last earningsNov 9, 2023
DataOct 2020–Sep 2026
Filing10-Q · Aug 11
Up next
filed Aug 11, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$1.00M
Trailing 12 months
Net income (TTM)
−$52.57M
Trailing 12 months
Revenue growth YoY
-82.5%
Year over year
Operating margin
-5,578.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$63.30M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+154.5%
Year over year · more shares
Price change (1Y)
+169.5%
Trailing year
Short interest
5.6%
Latest settlement · 7.6 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.8 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+6%
above
Price vs 50-day avg
−14%
below
RSI (14)
35
neutral
MACD trend
Negative
52-week position
67%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−17%
trailing
6-month return
0%
trailing
YTD return
+65%
this year
Relative strength
−20%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $6 — 50d above 200d
Institutional flow
Accumulating
+23% holders QoQ · +38 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.55% of float · ▼ -7.2% MoM · 7.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
103 holders — near 3-yr high, broad support
Squeeze score
60
elevated · 0–100
Fundamentals
Revenue growth
−83%
Y/Y
EPS growth
+53%
Y/Y
Free cash flow
$-40.0M
Quant / Vol
risk profile
Volatility
80%
annualized · 1-yr
Max drawdown
−51%
past year
ATR
6.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+6%
Bullish
Price vs 50-day avg
−14%
Bearish
RSI (14)
35
Neutral
MACD trend
Negative
Bearish
52-week position
67%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $7 › 200d $6 — 50d above 200d
Institutional flow
Accumulating
+23% holders QoQ · +38 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
5.55% of float · ▼ -7.2% MoM · 7.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
103 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $6 · 67%
Range high $8
vs 200-day avg +6%
vs 50-day avg -14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
STTK
this stock
Shattuck Labs, Inc.
|
$603.18M | +64.7% | -82.5% | — | 5.6% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$130.06B | +12.1% | +46.2% | 29.9 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$80.80B | +1.7% | +20.8% | 19.4 | 2.5% |
|
MRNA
Moderna, Inc.
|
$61.50B | +422.3% | +4.3% | — | 9.8% |
|
ARGX
Argenx SE
|
$60.93B | +17.8% | — | — | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| STTK | -3.1% | -17.1% | -0.2% | -14.3% | +64.7% |
| SPY | -0.3% | -0.1% | +20.1% | -0.7% | +11.7% |
| vs SPY | -2.7% | -17.0% | -20.3% | -13.6% | +53.0% |